Journal of Critical Care
Volume 23, Issue 1 , Pages 91-100, March 2008

Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: A meta-analysis

University of Connecticut School of Pharmacy, Storrs, CT

Hartford Hospital, Hartford, CT 06102

Abstract 

Objectives

Studies have found that initial treatment of ventilator-associated pneumonia (VAP) and blood stream infections (BSI) with inappropriate antimicrobial therapy is associated with higher rates of mortality, but additional studies have failed to confirm this.

Methods

Databases were searched to identify studies that met the following criteria: observational trials, patients with VAP or BSI receiving appropriate and inappropriate antimicrobial therapy, and mortality data. We conducted random-effects model meta-analyses, both with and without adjustment.

Results

Meta-analyses of VAP studies using unadjusted and adjusted data indicated that inappropriate therapy significantly increased patients' odds of mortality (odds ratio [OR], 2.34; 95% confidence interval [CI], 1.51-3.63; P = .0001, I2 = 28.5% and OR, 3.03; 95% CI, 1.12-8.19; P = .0292, I2 = 89.2%, respectively). Meta-analyses of BSI studies using unadjusted and adjusted data showed that inappropriate therapy significantly increased patients' odds of mortality (OR, 2.33; 95% CI, 1.96-2.76; P < .0001, I2 = 48.7% and OR, 2.28; 95% CI, 1.43-3.65; P = .0006, I2 = 88.2%, respectively).

Conclusions

There appears to be an association between initial inappropriate antimicrobial therapy and increased mortality in patients with VAP and BSI.

Keywords: Ventilators, Pneumonia, Bacteremia, Antibiotic, Mortality, Meta-analysis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was possible due to a grant from AstraZeneca Pharmaceuticals LP. There is no conflict of interest for any of the authors listed.

PII: S0883-9441(07)00148-7

doi:10.1016/j.jcrc.2007.08.007

Journal of Critical Care
Volume 23, Issue 1 , Pages 91-100, March 2008